Bio Similars/Subsequent Entry Biologic Market Report

Global and Region Bio Similars/Subsequent Entry Biologic Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：198
  • REPORT CODE：GMM967518
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Bio Similars/Subsequent Entry Biologic market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Bio Similars/Subsequent Entry Biologicmarket, defines the market attractiveness level of Bio Similars/Subsequent Entry Biologic market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Bio Similars/Subsequent Entry Biologic industry, describes the types of Bio Similars/Subsequent Entry Biologic market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bio Similars/Subsequent Entry Biologic market and the development prospects and opportunities of Bio Similars/Subsequent Entry Biologic industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bio Similars/Subsequent Entry Biologic market in Chapter 13.

    By Player:

    • Celltrion Biocon

    • Sanofi-Aventis

    • Biogen idec

    • Pfizer

    • Stada Arzneimittel AG

    • Merck

    • Biocon

    • LG Life Sciences

    • Samsung Biologics

    • Innovent

    • Gelgen

    • Amgen

    • Celltrion

    • Johnson & Johnson

    • Dong Bao

    • AbbVie

    • Biotech

    • Dr Reddy's Laboratories

    • Genentech (Roche)

    • Hospira

    • Synthon Pharmaceuticals

    • 3sbio

    • Sun Pharma

    • Teva Pharmaceutical Industries

    • Novartis

    • Mylan

    • Novo Nordisk

    • Ganlee

    • Eli Lilly

    By Type:

    • Monoclonal Antibodies

    • Interferon

    • Erythropoietin

    • Insulin

    • Vaccines

    • Other

    By End-User:

    • Tumor

    • Diabetes

    • Cardiovascular

    • Hemophilia

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Bio Similars/Subsequent Entry Biologic Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Bio Similars/Subsequent Entry Biologic Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Bio Similars/Subsequent Entry Biologic Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Bio Similars/Subsequent Entry Biologic Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Bio Similars/Subsequent Entry Biologic Market Analysis and Outlook to 2022

    • 7.1 Global Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)

    • 7.2 United States Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)

    • 7.3 Europe Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)

    • 7.4 China Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)

    • 7.5 Japan Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)

    • 7.6 India Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)

    • 7.7 South Korea Bio Similars/Subsequent Entry Biologic Consumption (2017-2022)

    8 Region and Country-wise Bio Similars/Subsequent Entry Biologic Market Analysis and Outlook to 2028

    • 8.1 Global Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)

    • 8.2 United States Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)

    • 8.3 Europe Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)

    • 8.4 China Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)

    • 8.5 Japan Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)

    • 8.6 India Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)

    • 8.7 South Korea Bio Similars/Subsequent Entry Biologic Consumption Forecast (2022-2028)

    9 Global Bio Similars/Subsequent Entry Biologic Market Outlook by Types and Applications to 2022

    • 9.1 Global Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Interferon Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Erythropoietin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Insulin Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Tumor Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cardiovascular Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Hemophilia Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Bio Similars/Subsequent Entry Biologic Market Outlook by Types and Applications to 2028

    • 10.1 Global Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Interferon Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Insulin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Tumor Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Bio Similars/Subsequent Entry Biologic Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Bio Similars/Subsequent Entry Biologic Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Bio Similars/Subsequent Entry Biologic Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Bio Similars/Subsequent Entry Biologic Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Bio Similars/Subsequent Entry Biologic Market Competitive Analysis

    • 14.1 Celltrion Biocon

      • 14.1.1 Celltrion Biocon Company Details

      • 14.1.2 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.2 Sanofi-Aventis

      • 14.2.1 Sanofi-Aventis Company Details

      • 14.2.2 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.3 Biogen idec

      • 14.3.1 Biogen idec Company Details

      • 14.3.2 Biogen idec Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Biogen idec Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.4 Pfizer

      • 14.4.1 Pfizer Company Details

      • 14.4.2 Pfizer Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Pfizer Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.5 Stada Arzneimittel AG

      • 14.5.1 Stada Arzneimittel AG Company Details

      • 14.5.2 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.6 Merck

      • 14.6.1 Merck Company Details

      • 14.6.2 Merck Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.7 Biocon

      • 14.7.1 Biocon Company Details

      • 14.7.2 Biocon Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Biocon Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.8 LG Life Sciences

      • 14.8.1 LG Life Sciences Company Details

      • 14.8.2 LG Life Sciences Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 LG Life Sciences Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.9 Samsung Biologics

      • 14.9.1 Samsung Biologics Company Details

      • 14.9.2 Samsung Biologics Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Samsung Biologics Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.10 Innovent

      • 14.10.1 Innovent Company Details

      • 14.10.2 Innovent Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Innovent Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.11 Gelgen

      • 14.11.1 Gelgen Company Details

      • 14.11.2 Gelgen Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Gelgen Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.12 Amgen

      • 14.12.1 Amgen Company Details

      • 14.12.2 Amgen Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Amgen Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.13 Celltrion

      • 14.13.1 Celltrion Company Details

      • 14.13.2 Celltrion Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Celltrion Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.14 Johnson & Johnson

      • 14.14.1 Johnson & Johnson Company Details

      • 14.14.2 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.15 Dong Bao

      • 14.15.1 Dong Bao Company Details

      • 14.15.2 Dong Bao Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Dong Bao Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.16 AbbVie

      • 14.16.1 AbbVie Company Details

      • 14.16.2 AbbVie Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 AbbVie Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.17 Biotech

      • 14.17.1 Biotech Company Details

      • 14.17.2 Biotech Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Biotech Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.18 Dr Reddy's Laboratories

      • 14.18.1 Dr Reddy's Laboratories Company Details

      • 14.18.2 Dr Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Dr Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.19 Genentech (Roche)

      • 14.19.1 Genentech (Roche) Company Details

      • 14.19.2 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.20 Hospira

      • 14.20.1 Hospira Company Details

      • 14.20.2 Hospira Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Hospira Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.21 Synthon Pharmaceuticals

      • 14.21.1 Synthon Pharmaceuticals Company Details

      • 14.21.2 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.22 3sbio

      • 14.22.1 3sbio Company Details

      • 14.22.2 3sbio Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 3sbio Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.23 Sun Pharma

      • 14.23.1 Sun Pharma Company Details

      • 14.23.2 Sun Pharma Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 Sun Pharma Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.24 Teva Pharmaceutical Industries

      • 14.24.1 Teva Pharmaceutical Industries Company Details

      • 14.24.2 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.24.3 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.25 Novartis

      • 14.25.1 Novartis Company Details

      • 14.25.2 Novartis Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.25.3 Novartis Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.26 Mylan

      • 14.26.1 Mylan Company Details

      • 14.26.2 Mylan Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.26.3 Mylan Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.27 Novo Nordisk

      • 14.27.1 Novo Nordisk Company Details

      • 14.27.2 Novo Nordisk Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.27.3 Novo Nordisk Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.28 Ganlee

      • 14.28.1 Ganlee Company Details

      • 14.28.2 Ganlee Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.28.3 Ganlee Bio Similars/Subsequent Entry Biologic Product and Service

    • 14.29 Eli Lilly

      • 14.29.1 Eli Lilly Company Details

      • 14.29.2 Eli Lilly Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.29.3 Eli Lilly Bio Similars/Subsequent Entry Biologic Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Bio Similars/Subsequent Entry Biologic

    • Figure Bio Similars/Subsequent Entry Biologic Picture

    • Table Global Bio Similars/Subsequent Entry Biologic Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Bio Similars/Subsequent Entry Biologic Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Bio Similars/Subsequent Entry Biologic Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Bio Similars/Subsequent Entry Biologic Consumption by Country (2017-2022)

    • Figure United States Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)

    • Table Europe Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)

    • Figure China Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)

    • Figure Japan Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)

    • Figure India Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)

    • Figure South Korea Bio Similars/Subsequent Entry Biologic Consumption and Growth Rate (2017-2022)

    • Figure Global Bio Similars/Subsequent Entry Biologic Consumption Forecast by Country (2022-2028)

    • Figure United States Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Bio Similars/Subsequent Entry Biologic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Interferon Consumption and Growth Rate (2017-2022)

    • Figure Global Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Global Insulin Consumption and Growth Rate (2017-2022)

    • Figure Global Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Consumption and Growth Rate (2017-2022)

    • Figure Global Hemophilia Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Interferon Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tumor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Bio Similars/Subsequent Entry Biologic Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Bio Similars/Subsequent Entry Biologic Export by Region (Top 5 Countries) (2017-2028)

    • Table Celltrion Biocon (Foundation Year, Company Profile and etc.)

    • Table Celltrion Biocon Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)

    • Table Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Biogen idec (Foundation Year, Company Profile and etc.)

    • Table Biogen idec Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen idec Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Stada Arzneimittel AG (Foundation Year, Company Profile and etc.)

    • Table Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Biocon (Foundation Year, Company Profile and etc.)

    • Table Biocon Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocon Bio Similars/Subsequent Entry Biologic Product and Service

    • Table LG Life Sciences (Foundation Year, Company Profile and etc.)

    • Table LG Life Sciences Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table LG Life Sciences Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Samsung Biologics (Foundation Year, Company Profile and etc.)

    • Table Samsung Biologics Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Samsung Biologics Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Innovent (Foundation Year, Company Profile and etc.)

    • Table Innovent Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Innovent Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Gelgen (Foundation Year, Company Profile and etc.)

    • Table Gelgen Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gelgen Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Celltrion (Foundation Year, Company Profile and etc.)

    • Table Celltrion Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltrion Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Dong Bao (Foundation Year, Company Profile and etc.)

    • Table Dong Bao Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dong Bao Bio Similars/Subsequent Entry Biologic Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Biotech (Foundation Year, Company Profile and etc.)

    • Table Biotech Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biotech Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Dr Reddy's Laboratories (Foundation Year, Company Profile and etc.)

    • Table Dr Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Genentech (Roche) (Foundation Year, Company Profile and etc.)

    • Table Genentech (Roche) Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Hospira (Foundation Year, Company Profile and etc.)

    • Table Hospira Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hospira Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Synthon Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product and Service

    • Table 3sbio (Foundation Year, Company Profile and etc.)

    • Table 3sbio Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3sbio Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Sun Pharma (Foundation Year, Company Profile and etc.)

    • Table Sun Pharma Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharma Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Ganlee (Foundation Year, Company Profile and etc.)

    • Table Ganlee Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ganlee Bio Similars/Subsequent Entry Biologic Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Bio Similars/Subsequent Entry Biologic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Bio Similars/Subsequent Entry Biologic Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US